Godavari Biorefineries Limited, one of the largest integrated bio-refineries, announced its financial results for the quarter and half year ended on Sep 30, 2026. The company achieved a significant turnaround with a positive EBITDA and revenue growth despite industry headwinds.

Key Financial Highlights

The consolidated total revenue for Q2 FY27 stood at Rs. 549.8 Cr, marking a 26.6% year-on-year growth. EBITDA turned positive at Rs. 10.9 Cr, a stark contrast to the negative EBITDA of Rs. 4.4 Cr in Q2 FY26. For the half year, the revenue reached Rs. 1,109.7 Cr, up from Rs. 968.2 Cr in H1 FY26. The EBITDA improved to Rs. 13.4 Cr from Rs. 2.1 Cr in H1 FY26.

Segment Performance

The Bio-based Chemicals segment showed robust growth with revenue increasing by approximately 39% year-on-year to Rs. 204.2 Cr. The segment EBITDA surged by 47% to Rs. 22.1 Cr. On the other hand, the Integrated Sugar, Co-gen & Ethanol segment faced challenges with revenue of Rs. 334.2 Cr and a negative EBITDA of Rs. 8.7 Cr.

Looking Ahead

Shri Samir Somaiya, CMD, emphasized the company’s focus on operational efficiencies, portfolio diversification, and disciplined execution. The company continues to pursue further capacity optimization, process improvements, and product development to capture opportunities across domestic and international markets. Innovation remains a key pillar with several patents secured globally for novel anti-cancer molecules and bio-based technologies.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Godavari Biorefineries Limited

Godavari Biorefineries Limited belongs to the Basic Materials › Chemicals sector. Here’s a quick read on where the business and the stock stand today.

Godavari trades in the lower quarter of its 52-week range. Razor-thin margins below 5% make profitability extremely vulnerable — this business needs scale or pricing power urgently. 3 loss quarters over five years is a serious red flag — earnings quality is poor and recovery is not guaranteed. The stock sits at 14% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. Revenue grows at -0.4% CAGR and the PEG stands at 99.00. The growth does not match the price the market asks. Furthermore, flat price action adds no technical catalyst. A lower price or faster revenue growth would improve the odds. Check Fundamentals of Godavari Biorefineries Limited.

India Pesticides Limited (IPL) has reported robust financial results for Q2 FY27, with revenue from operations increasing by 21.6% year-on-year to Rs. 231 crore. The company’s profit after tax (PAT) also saw a significant rise of 41.7% to Rs. 18 crore. Despite a challenging operating environment with geopolitical uncertainties and volatility in raw material prices, IPL managed to maintain operational discipline and focus on cost management.

Financial Highlights

The company’s earnings before tax (EBITDA) surged by 38.0% to Rs. 33 crore, with an EBITDA margin of 14.4%. The gross profit increased by 11.2% to Rs. 117 crore, maintaining a gross profit margin of 50.5%. The effective utilization of resources and strategic cost management helped IPL navigate through the difficult conditions.

Strategic Initiatives

IPL continues to prioritize its international growth strategy. The company has received Technical Equivalence approval for one of its insecticide products in the United Kingdom and registration for one of its herbicide products in Argentina. These achievements open new avenues for IPL to engage with international customers and expand its export portfolio. The company’s vision remains focused on building a more diversified, globally competitive agrochemical business.

Future Outlook

Looking ahead, IPL aims to pursue product registrations in regulated markets, deepen customer engagement, and strengthen its manufacturing capabilities. With a strong net cash position and continuous process optimization, IPL is well-positioned to drive sustainable earnings growth and create long-term value for its stakeholders.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of India Pesticides Limited

India Pesticides Limited belongs to the Basic Materials › Agricultural Inputs sector. Here’s a quick read on where the business and the stock stand today.

India drops 16.3% over three months and trades near its 52-week lows. Revenue contracts at 6.2% CAGR. That signals structural headwinds, not a short-term blip. The stock sits at 3% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. Revenue grows at 6.2% CAGR and the PEG stands at 99.00. The growth does not match the price the market asks. Furthermore, flat price action adds no technical catalyst. A lower price or faster revenue growth would improve the odds. Check Fundamentals of India Pesticides Limited.

Dharmaj Crop Guard Limited (NSE: DHARMAJ), one of the fastest-growing agrochemicals companies, announced its financial results for Q2 & H1 FY27. Despite the weak monsoon season, the company has managed to maintain steady revenue. Revenue from operations for the half year stood at ₹716.7 crore, in line with ₹714.6 crore in H1 FY26. For Q2 FY27, revenue from operations registered a marginal decline of 4% YOY to ₹332.6 crore, primarily due to lower sales in the Technicals division.

Financial Highlights

EBITDA margin for H1 FY27 stood at 11.4%, flat against 11.5% in H1 FY26. Profit After Tax for H1 FY27 stood at ₹51.3 crore, up 3% YOY. Q2 FY27 saw a compression in margins, this was on account of higher input costs across the board, as purchases made after the West Asia crisis are now flowing through the system, coupled with tepid margins in the Technicals business.

Business Segment Performance

Within our business mix, Formulations have remained resilient, both Institutional and Branded. Institutional Formulations registered growth of 2% YOY in Q2 and 3% YOY in H1 FY27. Branded Formulations grew 5% YOY in Q2 and 2% YOY in H1 FY27. Our Exports business has also remained steady. Export revenue was flat YOY in Q2, while H1 FY27 exports grew 50% YOY, carrying forward the recovery we saw through FY26.

The main headwind this quarter has been in our Technicals business, which registered a 27% YOY decline in Q2 and a 20% YOY decline in H1 FY27. As discussed, the West Asia crisis has affected both input pricing and demand patterns in the Technicals market, and we continue to remain agile in this business until conditions normalise. Looking ahead, we maintain a cautiously optimistic outlook for the second half of the financial year.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Dharmaj Crop Guard Limited

Dharmaj Crop Guard Limited belongs to the Basic Materials › Agricultural Inputs sector. Here’s a quick read on where the business and the stock stand today.

Dharmaj posts a 0.9% three-month gain, but softens in the last few weeks. The PEG of 0.55 signals undervaluation relative to growth. It is a potential re-rating candidate. Thin margins at 5.2% leave limited room for error — any demand softness or cost spike hits the bottom line hard. The stock gives back 3.2% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. Revenue grows at 29.5% and profits at 26.7%. The business is in good shape. Moreover, a stock that does not move despite strong fundamentals often offers better value than one already priced for perfection. Check Fundamentals of Dharmaj Crop Guard Limited.